Humacyte, Inc. (HUMA) reporting calendar
Humacyte, Inc. files periodic reports with the SEC as HUMA on Nasdaq. Atlas tracks 23 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 18 Jul 2026 – 6 Sep 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 13 May 2026
- Reports on record
- 23
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 43 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open HUMA market profile
Latest filing on SEC EDGAR ↗
Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 13 May 2026 | 43 days | 0001193125-26-221755 |
| 10-K | 31 Dec 2025 | 27 Mar 2026 | 86 days | 0001818382-26-000004 |
| 10-Q | 30 Sep 2025 | 12 Nov 2025 | 43 days | 0001818382-25-000132 |
| 10-Q | 30 Jun 2025 | 11 Aug 2025 | 42 days | 0001818382-25-000125 |
| 10-Q | 31 Mar 2025 | 13 May 2025 | 43 days | 0001818382-25-000076 |
| 10-K | 31 Dec 2024 | 31 Mar 2025 | 90 days | 0001818382-25-000034 |
| 10-Q | 30 Sep 2024 | 8 Nov 2024 | 39 days | 0001818382-24-000199 |
| 10-Q | 30 Jun 2024 | 13 Aug 2024 | 44 days | 0001818382-24-000156 |
| 10-Q | 31 Mar 2024 | 13 May 2024 | 43 days | 0001818382-24-000056 |
| 10-K | 31 Dec 2023 | 28 Mar 2024 | 88 days | 0001818382-24-000040 |
| 10-Q | 30 Sep 2023 | 9 Nov 2023 | 40 days | 0001818382-23-000162 |
| 10-Q | 30 Jun 2023 | 14 Aug 2023 | 45 days | 0001818382-23-000114 |
| 10-Q | 31 Mar 2023 | 12 May 2023 | 42 days | 0001818382-23-000030 |
| 10-K | 31 Dec 2022 | 24 Mar 2023 | 83 days | 0001818382-23-000016 |
| 10-Q | 30 Sep 2022 | 10 Nov 2022 | 41 days | 0001818382-22-000180 |
| 10-Q | 30 Jun 2022 | 12 Aug 2022 | 43 days | 0001818382-22-000105 |
| 10-Q | 31 Mar 2022 | 13 May 2022 | 43 days | 0001818382-22-000039 |
| 10-K | 31 Dec 2021 | 29 Mar 2022 | 88 days | 0001818382-22-000011 |
| 10-Q | 30 Sep 2021 | 15 Nov 2021 | 46 days | 0001104659-21-138285 |
| 10-Q | 30 Jun 2021 | 16 Aug 2021 | 47 days | 0001213900-21-043027 |
| 10-Q | 31 Mar 2021 | 17 May 2021 | 47 days | 0001213900-21-026966 |
| 10-K | 31 Dec 2020 | 16 Feb 2021 | 47 days | 0001213900-21-009571 |
| 10-Q | 30 Sep 2020 | 13 Nov 2020 | 44 days | 0001213900-20-036665 |
Source: SEC EDGAR company submissions for CIK 0001818382. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.